Hims & Hers reported a double beat in Q4, but faced an 18% stock drop after hours. Read why this drop is a good opportunity ...

Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Here's why TFSA investors should consider holding quality growth stocks such as HIMS and benefit from outsized gains over time. The post TFSA $7K: Where to Invest Right Now appeared first on The ...

Hims & Hers Health shares jumped some 20% to a record high on Wednesday following the announcement that it acquired lab ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of US-based Trybe Labs. This strategic move is set to enhance the company ...

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of ...

Investing.com -- Shares of Hims & Hers Health Inc. (NYSE:HIMS) surged 15.7% on Wednesday following the announcement that the company has acquired Trybe Labs, an at-home lab testing facility.

New service will enable blood testing for hormone levels, cardiac risk, thyroid function, and more using a blood lancet.

Hims & Hers is introducing at-home laboratory testing, expanding its platform to offer deeper health insights and more ...

Online health and wellness company Hims & Hers reported fourth-quarter earnings that beat Wall Street analysts' expectations ...